Reports link bone-building drugs to rare leg fracture

07/15/2008 |

Case studies on a rare type of leg fracture after little or no trauma among people who took bisphosphonates for five years or more have raised concerns that long-term use of the bone-building drugs may actually weaken bones. Merck & Co.'s Fosamax was cited in the reports, and the company said it will investigate whether the fracture pattern can be found commonly in people who take bone medicines.

View Full Article in:

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
In house Compliance Officer
Pompano Beach, FL